부산대학교 도서관

Segura-Roman, Ashley; Citron, Y Rose; Shin, Myungsun; Sindoni, Nicole; Maya-Romero, Alex; Rapp, Simon; Goul, Claire; Mancias, Joseph D; Zoncu, Roberto

EMBO Journal. Jun2025, Vol. 44 Issue 11, p3150-3179. 30p.

Loke, Justin CT ; Kim, Geon Geon ; Boileau, Meaghan ; Nguyen, Thuy T.P. ; McConkey, Marie E ; Miller, Aidan P. ; Shin, Wesley ; Hergott, Christopher B. ; Ericsson, Maria ; Nordstrom, Anja E.H. ; Armstrong, Scott A ; Mancias, Joseph D ; Ebert, Benjamin Levine

In Blood 5 November 2024 144 Supplement 1:188-188

Zhang H; Division of Radiation and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Santana-Codina N; Division of Radiation and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. nsc@biomed.au.dk.; Department of Biomedicine, Aarhus University, Aarhus, Denmark. nsc@biomed.au.dk.; Yu Q; Division of Radiation and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Poupault C; Division of Radiation and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Campos C; Division of Radiation and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Qin X; John B. Little Center for Radiation Sciences, Harvard T.H. Chan School of Public Health, Boston, MA, USA.; Laboratory of Systems Pharmacology, Harvard Program in Therapeutic Science, Department of Systems Biology, Harvard Medical School, Boston, MA, USA.; Molecular and Integrative Physiological Sciences Program, Harvard T.H. Chan School of Public Health, Boston, MA, USA.; Sindoni N; Division of Radiation and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Ciscar M; Department of Biomedicine, Aarhus University, Aarhus, Denmark.; Padhye A; Division of Radiation and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Kuljanin M; Division of Radiation and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Wang J; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Dorman MJ; Division of Radiation and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Bross P; Research Unit for Molecular Medicine, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark.; Aguirre AJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Dougan SK; Department of Immunology, Harvard Medical School, Boston, MA, USA.; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.; Sarosiek KA; John B. Little Center for Radiation Sciences, Harvard T.H. Chan School of Public Health, Boston, MA, USA.; Laboratory of Systems Pharmacology, Harvard Program in Therapeutic Science, Department of Systems Biology, Harvard Medical School, Boston, MA, USA.; Molecular and Integrative Physiological Sciences Program, Harvard T.H. Chan School of Public Health, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Mancias JD; Division of Radiation and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Joseph_Mancias@dfci.harvard.edu.; Department of Radiation Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Joseph_Mancias@dfci.harvard.edu.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Chen B; Cellular and Molecular Biology Program, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, MI 48109, USA.; Stark DC; Department of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, MI 48109, USA; Cancer Biology Program, University of Michigan Medical School, Ann Arbor, MI 48109, USA.; Jadhav PV; Life Sciences Institute, University of Michigan, Ann Arbor, MI 48109, USA; Department of Cell and Developmental Biology, University of Michigan, Ann Arbor, MI 48109, United States.; Lynn-Nguyen TM; Department of Medicinal Chemistry, College of Pharmacy, University of Michigan, Ann Arbor, MI 48109, USA; Department of Internal Medicine, Division of Gastroenterology and Hepatology, Michigan Medicine at the University of Michigan, Ann Arbor, MI 48109, USA; College of Pharmacy, University of Michigan, Ann Arbor, MI 48109, USA.; Halligan BS; Department of Medicinal Chemistry, College of Pharmacy, University of Michigan, Ann Arbor, MI 48109, USA; Department of Internal Medicine, Division of Gastroenterology and Hepatology, Michigan Medicine at the University of Michigan, Ann Arbor, MI 48109, USA.; Rossiter NJ; Cellular and Molecular Biology Program, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, MI 48109, USA.; Sindoni N; Division of Radiation and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Shin M; Division of Radiation and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Department of Cell Biology, Harvard Medical School, Boston, MA, USA.; Paulo JA; Department of Cell Biology, Harvard Medical School, Boston, MA, USA.; Chang M; Life Sciences Institute, University of Michigan, Ann Arbor, MI 48109, USA; Department of Cell and Developmental Biology, University of Michigan, Ann Arbor, MI 48109, United States.; Koo I; Department of Veterinary and Biomedical Sciences, Pennsylvania State University, University Park, State College, PA, USA.; Koshkin S; Huck Institutes of the Life Sciences, Pennsylvania State University, University Park, State College, PA, USA.; Eyunni S; Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan, Ann Arbor, MI 48109, USA; Molecular and Cellular Pathology Program, University of Michigan, Ann Arbor, MI 48109, USA.; Ronchi P; Electron Microscopy Core Facility, European Molecular Biology Laboratory, 69117 Heidelberg, Germany.; Paulsen MT; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI 48109, USA.; Greenbaum HS; Cellular and Molecular Biology Program, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, MI 48109, USA.; Ruckert MT; Department of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, MI 48109, USA.; Morlacchi P; Agilent Technologies, Inc., Lexington, MA 02421, USA.; Hanna DA; Department of Biological Chemistry, University of Michigan Medical School, Ann Arbor, MI 48109, USA.; Lin J; Department of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, MI 48109, USA.; Guerra RM; Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, MO 63110, USA.; Liu T; Department of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, MI 48109, USA.; Pagliarini DJ; Departament of Genetics, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, MO 63110, USA; Howard Hughes Medical Institute, St. Louis, MO 63110, USA.; Banerjee R; Department of Biological Chemistry, University of Michigan Medical School, Ann Arbor, MI 48109, USA.; Parolia A; Cancer Biology Program, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan, Ann Arbor, MI 48109, USA; Department of Urology, University of Michigan, Ann Arbor, MI 48109, USA.; Ljungman ME; Cancer Biology Program, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI 48109, USA.; Patterson AD; Department of Veterinary and Biomedical Sciences, Pennsylvania State University, University Park, State College, PA, USA.; Mancias JD; Division of Radiation and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Mosalaganti S; Life Sciences Institute, University of Michigan, Ann Arbor, MI 48109, USA; Department of Cell and Developmental Biology, University of Michigan, Ann Arbor, MI 48109, United States; Department of Biological Chemistry, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Biophysics, College of Literature, Science and the Arts, University of Michigan, Ann Arbor, MI 48109, USA.; Sexton JZ; Department of Medicinal Chemistry, College of Pharmacy, University of Michigan, Ann Arbor, MI 48109, USA; Department of Internal Medicine, Division of Gastroenterology and Hepatology, Michigan Medicine at the University of Michigan, Ann Arbor, MI 48109, USA; College of Pharmacy, University of Michigan, Ann Arbor, MI 48109, USA; Center for Drug Repurposing, University of Michigan, Ann Arbor, MI 48109, USA; Michigan Institute for Clinical and Health Research, University of Michigan, Ann Arbor, MI 48109, USA.; Calì T; Department of Biomedical Sciences, University of Padova, 35131 Padova, Italy; Padova Neuroscience Center (PNC), University of Padova, 35131 Padova, Italy; Center for Neurodegenerative Disease Research (CESNE), University of Padova, 35131 Padova, Italy.; Lyssiotis CA; Cellular and Molecular Biology Program, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, MI 48109, USA; Cancer Biology Program, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Internal Medicine, Division of Gastroenterology and Hepatology, Michigan Medicine at the University of Michigan, Ann Arbor, MI 48109, USA; Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA. Electronic address: clyssiot@umich.edu.; Shah YM; Cellular and Molecular Biology Program, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, MI 48109, USA; Cancer Biology Program, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Internal Medicine, Division of Gastroenterology and Hepatology, Michigan Medicine at the University of Michigan, Ann Arbor, MI 48109, USA; Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA. Electronic address: shahy@umich.edu.

Publisher: Cell Press Country of Publication: United States NLM ID: 9802571 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-4164 (Electronic) Linking ISSN: 10972765 NLM ISO Abbreviation: Mol Cell Subsets: MEDLINE

Ozawa H; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Takahashi K; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Motegi T; Cooperative Department of Veterinary Medicine, Tokyo University of Agriculture and Technology, Tokyo, Japan.; Jacobi J; Department of Biostatistics & Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, New York.; Bhattarchya A; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Shigeta K; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Takamori S; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Onishi M; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Luan Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Fukuda K; Department of Surgery, Keio University School of Medicine, Tokyo, Japan.; Ueno A; Division of Diagnostic Pathology, Keio University School of Medicine, Shinjuku-ku, Japan.; Kitago M; Department of Surgery, Keio University School of Medicine, Tokyo, Japan.; Kawakubo H; Department of Surgery, Keio University School of Medicine, Tokyo, Japan.; Kitagawa Y; Department of Surgery, Keio University School of Medicine, Tokyo, Japan.; Keith D; Brenden-Colson Center for Pancreatic Care, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.; Muschler J; Brenden-Colson Center for Pancreatic Care, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.; Sears RC; Brenden-Colson Center for Pancreatic Care, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.; Long MD; Department of Biostatistics & Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, New York.; Mancias JD; Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Aguirre AJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Kufe D; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Parikh, Parag Jitendra; Lee, Percy; Low, Daniel A; Kim, Joshua; Mittauer, Kathryn E; Bassetti, Michael F; Glide-Hurst, Carri K; Raldow, Ann C; Yang, Yingli; Portelance, Lorraine; Padgett, Kyle R; Zaki, Bassem; Zhang, Rongxiao; Kim, Hyun; Henke, Lauren E; Price, Alex T; Mancias, Joseph D; Williams, Christopher L; Ng, John; Pennell, Ryan; Pfeffer, M Raphael; Levin, Daphne; Mueller, Adam C; Mooney, Karen E; Kelly, Patrick; Shah, Amish P; Boldrini, Luca; Placidi, Lorenzo; Fuss, Martin; Chuong, Michael D

International Journal of Radiation Oncology*Biology*Physics. 117:799-808

Leeman JE; Department of Radiation Oncology, Brigham and Women's Hospital/Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.; Shin KY; Department of Radiation Oncology, Brigham and Women's Hospital/Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.; Department of Data Science, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.; Droznin A; Department of Radiation Oncology, Brigham and Women's Hospital/Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.; Catalano P; Department of Radiation Oncology, Brigham and Women's Hospital/Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.; Department of Data Science, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.; Cagney DN; Department of Radiation Oncology, Brigham and Women's Hospital/Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.; Singer L; Department of Radiation Oncology, Brigham and Women's Hospital/Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.; Oniyangi RD; Department of Radiation Oncology, Brigham and Women's Hospital/Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.; Zhai K; Department of Radiation Oncology, Brigham and Women's Hospital/Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.; Benham G; Department of Radiation Oncology, Brigham and Women's Hospital/Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.; Chirmade S; Department of Radiation Oncology, Brigham and Women's Hospital/Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.; Campbell J; Department of Radiation Oncology, Brigham and Women's Hospital/Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.; Boyle S; Department of Radiation Oncology, Brigham and Women's Hospital/Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.; Saranteas A; Department of Radiation Oncology, Brigham and Women's Hospital/Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.; Williams CL; Department of Radiation Oncology, Brigham and Women's Hospital/Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.; Huynh E; Department of Radiation Oncology, Brigham and Women's Hospital/Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.; Han Z; Department of Radiation Oncology, Brigham and Women's Hospital/Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.; Sudhyadhom A; Department of Radiation Oncology, Brigham and Women's Hospital/Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.; Hu YH; Department of Radiation Oncology, Brigham and Women's Hospital/Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.; Ferguson D; Department of Radiation Oncology, Brigham and Women's Hospital/Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.; Singhrao K; Department of Radiation Oncology, Brigham and Women's Hospital/Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.; Hsu SH; Department of Radiation Oncology, Brigham and Women's Hospital/Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.; Bredfeldt J; Department of Radiation Oncology, Brigham and Women's Hospital/Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.; Martin NE; Department of Radiation Oncology, Brigham and Women's Hospital/Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.; Mancias JD; Department of Radiation Oncology, Brigham and Women's Hospital/Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.; Mamon HJ; Department of Radiation Oncology, Brigham and Women's Hospital/Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.; Van Dams R; Department of Radiation Oncology, Brigham and Women's Hospital/Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.; Venkatachalam V; Department of Radiation Oncology, Brigham and Women's Hospital/Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.; Tanguturi SK; Department of Radiation Oncology, Brigham and Women's Hospital/Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.; Huynh MA; Department of Radiation Oncology, Brigham and Women's Hospital/Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.; Fitzgerald KJ; Department of Radiation Oncology, Brigham and Women's Hospital/Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.; Elhalawani H; Department of Radiation Oncology, Brigham and Women's Hospital/Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.; Bitterman DS; Department of Radiation Oncology, Brigham and Women's Hospital/Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.; Schoenfeld JD; Department of Radiation Oncology, Brigham and Women's Hospital/Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.; Nguyen P; Department of Radiation Oncology, Brigham and Women's Hospital/Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.; Haas-Kogan DA; Department of Radiation Oncology, Brigham and Women's Hospital/Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.; Mak R; Department of Radiation Oncology, Brigham and Women's Hospital/Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.

Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE

Guo JA; Broad Institute of MIT and Harvard, Cambridge, MA, USA; School of Medicine, University of California, San Francisco, San Francisco, CA, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Gong D; Broad Institute of MIT and Harvard, Cambridge, MA, USA; Massachusetts Institute of Technology, Cambridge, MA, USA; Center for Systems Biology, Krantz Family Center for Cancer Research, Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.; Evans K; Broad Institute of MIT and Harvard, Cambridge, MA, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.; Takahashi K; Broad Institute of MIT and Harvard, Cambridge, MA, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.; Jambhale AD; Grossman School of Medicine, New York University, New York, NY, USA.; Shiau C; Harvard Medical School, Boston, MA, USA.; Yu P; University of Washington, Seattle, WA, USA.; Wang S; Stanford University, Stanford, CA, USA.; Wu WW; Harvard Medical School, Boston, MA, USA.; Chugh S; Broad Institute of MIT and Harvard, Cambridge, MA, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Kapner KS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Dilly J; Broad Institute of MIT and Harvard, Cambridge, MA, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Zhao D; New York Medical College, Valhalla, NY, USA.; Chen P; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Smith EL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Mancias JD; Harvard Medical School, Boston, MA, USA; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Vazquez F; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Singh H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Hwang WL; Broad Institute of MIT and Harvard, Cambridge, MA, USA; Center for Systems Biology, Krantz Family Center for Cancer Research, Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. Electronic address: whwang1@mgh.harvard.edu.; Aguirre AJ; Broad Institute of MIT and Harvard, Cambridge, MA, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. Electronic address: andrew_aguirre@dfci.harvard.edu.

Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-1247 (Electronic) NLM ISO Abbreviation: Cell Rep Subsets: MEDLINE

Loke J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.; Kim PG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Cancer Center, Mass General Research Institute, Massachusetts General Hospital, Boston, MA.; Nguyen TTP; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA.; Boileau M; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.; McConkey M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Miller A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Shin W; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Hergott CB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA.; Ericsson M; Department of Cell Biology, Harvard Medical School, Boston, MA.; Nordstrom A; Department of Cell Biology, Harvard Medical School, Boston, MA.; Llopis PM; MicRoN Core, Harvard Medical School, Boston, MA.; Armstrong SA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.; Mancias JD; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA.; Ebert BL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Broad Institute, Cambridge, MA.

Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Surana R; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Morgado M; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Somasundaram A; Division of Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.; Bockorny B; Department of Medical Oncology, Beth Israel Deaconess Hospital and Harvard Medical School, Boston, MA.; Weekes CD; Department of Medical Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA.; Coleman EC; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Bird A; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Wang J; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Williams HL; Department of Pathology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Zheng H; Biostatistics Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA.; Brais LK; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Saxena N; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Graham C; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Ritterband L; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Sawin M; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Peters ML; Department of Medical Oncology, Beth Israel Deaconess Hospital and Harvard Medical School, Boston, MA.; Whooley P; Department of Medical Oncology, Beth Israel Deaconess Hospital and Harvard Medical School, Boston, MA.; Bullock A; Department of Medical Oncology, Beth Israel Deaconess Hospital and Harvard Medical School, Boston, MA.; Zerillo J; Department of Medical Oncology, Beth Israel Deaconess Hospital and Harvard Medical School, Boston, MA.; Sanoff HK; Division of Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.; Clark JW; Department of Medical Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA.; Parikh AR; Department of Medical Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA.; Yurgelun MB; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Patel AK; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Mayer RJ; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Cleary JM; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Enzinger P; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Rubinson DA; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; McCleary NJ; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Enzinger A; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Slater S; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Ng K; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Biller LH; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Abrams TA; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Huffman BM; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Singh H; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Raghavan S; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Mancias JD; Department of Radiation Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Bryant KL; Department of Pharmacology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.; Nowak JO; Department of Pathology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.; Aguirre AJ; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Der CJ; Department of Pharmacology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.; Wolpin BM; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Perez K; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE

DeAngelo SL; Doctoral Program in Cancer Biology, University of Michigan Medical School, Ann Arbor, Michigan.; Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan.; Department of Chemistry, University of Michigan, Ann Arbor, Michigan.; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.; Zhao L; Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan.; Dziechciarz S; Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan.; Shin M; Department of Cell Biology, Harvard Medical School, Boston, Massachusetts.; Dana-Farber Cancer Institute, Boston, Massachusetts.; Solanki S; Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan.; Balia A; Department of Medicinal Chemistry, College of Pharmacy, University of Michigan, Ann Arbor, Michigan.; El-Derany MO; Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan.; Department of Biochemistry, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt.; Castillo C; Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan.; Qin Y; School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Sha Tin, Hong Kong.; Li Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Sha Tin, Hong Kong.; Das NK; Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan.; Bell HN; Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan.; Paulo JA; Department of Cell Biology, Harvard Medical School, Boston, Massachusetts.; Dana-Farber Cancer Institute, Boston, Massachusetts.; Zhang Y; Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan.; Rossiter NJ; Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan.; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.; McCulla EC; Doctoral Program in Cancer Biology, University of Michigan Medical School, Ann Arbor, Michigan.; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.; He J; Department of Biological Sciences, University of Notre Dame, Notre Dame, Indiana.; Talukder I; Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan.; Ng BW; School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Sha Tin, Hong Kong.; Li Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Sha Tin, Hong Kong.; Schafer ZT; Department of Biological Sciences, University of Notre Dame, Notre Dame, Indiana.; Neamati N; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.; Department of Medicinal Chemistry, College of Pharmacy, University of Michigan, Ann Arbor, Michigan.; Mancias JD; Dana-Farber Cancer Institute, Boston, Massachusetts.; Division of Radiation and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Koutmos M; Department of Chemistry, University of Michigan, Ann Arbor, Michigan.; Division of Radiation and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Department of Biophysics, University of Michigan, Ann Arbor, Michigan.; Shah YM; Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan.; Department of Biophysics, University of Michigan, Ann Arbor, Michigan.; Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE

Ravichandran, Mirunalini; Hu, Jingjie; Cai, Charles; Ward, Nathan P; Venida, Anthony; Foakes, Callum; Kuljanin, Miljan; Yang, Annan; Hennessey, Connor J; Yang, Yang; Desousa, Brandon R; Rademaker, Gilles; Staes, Annelot A L; Cakir, Zeynep; Jain, Isha H; Aguirre, Andrew J; Mancias, Joseph D; Shen, Yin; DeNicola, Gina M; Perera, Rushika M

Cancer Discovery, vol 12, iss 9

Lin, Shan; Larrue, Clément; Scheidegger, Nastassja K; Seong, Bo Kyung A.; Dharia, Neekesh V; Kuljanin, Miljan; Wechsler, Caroline S; Kugener, Guillaume; Robichaud, Amanda L; Saur Conway, Amy; Mashaka, Thelma; Mouche, Sarah; Adane, Biniam; Ryan, Jeremy A; Mancias, Joseph D; Younger, Scott T; Piccioni, Federica; Lee, Lynn H; Wunderlich, Mark; Letai, Anthony; Tamburini Bonnefoy, Jérôme; Stegmaier, Kimberly

Cancer Discov

Han Z; Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Sudhyadhom A; Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Hsu SH; Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Hu YH; Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Mak RH; Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Huynh MA; Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; van Dams RR; Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Tanguturi S; Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Venkatachalam V; Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Mancias JD; Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Mamon HJ; Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Martin NE; Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Lam MB; Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Leeman JE; Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.

Publisher: Wiley on behalf of American Association of Physicists in Medicine Country of Publication: United States NLM ID: 101089176 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1526-9914 (Electronic) Linking ISSN: 15269914 NLM ISO Abbreviation: J Appl Clin Med Phys Subsets: MEDLINE

Fisher AL; Nephrology Division and Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA.; Phillips S; Nephrology Division and Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA.; Wang CY; Nephrology Division and Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA.; Paulo JA; Department of Cell Biology, Harvard Medical School, Boston, MA.; Xiao X; Nephrology Division and Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA.; Xu Y; Nephrology Division and Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA.; Moschetta GA; Nephrology Division and Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA.; Xue Y; Nephrology Division and Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA.; Mancias JD; Division of Radiation and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Babitt JL; Nephrology Division and Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA.

Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Herhaus L; Institute of Biochemistry II, Goethe University Frankfurt, Medical Faculty, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany. Electronic address: lina.herhaus@gmail.com.; Gestal-Mato U; Institute of Biochemistry II, Goethe University Frankfurt, Medical Faculty, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany.; Eapen VV; Division of Radiation and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Institutes of Medicine, 450 Brookline Avenue, Boston, MA 02215, USA; Department of Cell Biology, Harvard Medical School, 240 Longwood Avenue, Boston, MA 02115, USA.; Mačinković I; Institute of Biochemistry II, Goethe University Frankfurt, Medical Faculty, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany; Institute of Biochemistry I, Goethe University School of Medicine, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany.; Bailey HJ; Institute of Biochemistry II, Goethe University Frankfurt, Medical Faculty, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany; Buchmann Institute for Molecular Life Sciences, Goethe University Frankfurt, Riedberg Campus, Max-von-Laue-Straße 15, 60438 Frankfurt am Main, Germany.; Prieto-Garcia C; Institute of Biochemistry II, Goethe University Frankfurt, Medical Faculty, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany.; Misra M; Institute of Biochemistry II, Goethe University Frankfurt, Medical Faculty, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany; Buchmann Institute for Molecular Life Sciences, Goethe University Frankfurt, Riedberg Campus, Max-von-Laue-Straße 15, 60438 Frankfurt am Main, Germany.; Jacomin AC; Institute of Biochemistry II, Goethe University Frankfurt, Medical Faculty, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany.; Ammanath AV; Institute of Biochemistry II, Goethe University Frankfurt, Medical Faculty, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany.; Bagarić I; Institute of Biochemistry II, Goethe University Frankfurt, Medical Faculty, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany.; Michaelis J; Institute of Biochemistry II, Goethe University Frankfurt, Medical Faculty, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany.; Vollrath J; Institute of Biochemistry II, Goethe University Frankfurt, Medical Faculty, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany; Buchmann Institute for Molecular Life Sciences, Goethe University Frankfurt, Riedberg Campus, Max-von-Laue-Straße 15, 60438 Frankfurt am Main, Germany; Max Planck Institute of Biophysics, Goethe University Frankfurt, Riedberg Campus, 60438 Frankfurt am Main, Germany.; Bhaskara RM; Institute of Biochemistry II, Goethe University Frankfurt, Medical Faculty, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany; Buchmann Institute for Molecular Life Sciences, Goethe University Frankfurt, Riedberg Campus, Max-von-Laue-Straße 15, 60438 Frankfurt am Main, Germany.; Bündgen G; Institute for Immunology, University Medical Center, Johannes Gutenberg University Mainz, Mainz, Germany.; Covarrubias-Pinto A; Institute of Biochemistry II, Goethe University Frankfurt, Medical Faculty, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany.; Husnjak K; Institute of Biochemistry II, Goethe University Frankfurt, Medical Faculty, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany.; Zöller J; Max Planck Institute of Biophysics, Goethe University Frankfurt, Riedberg Campus, 60438 Frankfurt am Main, Germany.; Gikandi A; Division of Radiation and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Institutes of Medicine, 450 Brookline Avenue, Boston, MA 02215, USA.; Ribičić S; Institute of Biochemistry II, Goethe University Frankfurt, Medical Faculty, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany.; Bopp T; Institute for Immunology, University Medical Center, Johannes Gutenberg University Mainz, Mainz, Germany.; van der Heden van Noort GJ; Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, the Netherlands.; Langer JD; Max Planck Institute of Biophysics, Goethe University Frankfurt, Riedberg Campus, 60438 Frankfurt am Main, Germany.; Weigert A; Institute of Biochemistry I, Goethe University School of Medicine, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany.; Harper JW; Department of Cell Biology, Harvard Medical School, 240 Longwood Avenue, Boston, MA 02115, USA.; Mancias JD; Division of Radiation and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Institutes of Medicine, 450 Brookline Avenue, Boston, MA 02215, USA.; Dikic I; Institute of Biochemistry II, Goethe University Frankfurt, Medical Faculty, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany; Buchmann Institute for Molecular Life Sciences, Goethe University Frankfurt, Riedberg Campus, Max-von-Laue-Straße 15, 60438 Frankfurt am Main, Germany; Max Planck Institute of Biophysics, Goethe University Frankfurt, Riedberg Campus, 60438 Frankfurt am Main, Germany. Electronic address: dikic@biochem2.uni-frankfurt.de.

Publisher: Cell Press Country of Publication: United States NLM ID: 0413066 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-4172 (Electronic) Linking ISSN: 00928674 NLM ISO Abbreviation: Cell Subsets: MEDLINE

Smyczynska U; Department of Biostatistics and Translational Medicine, Medical University of Lodz, 92-215 Lodz, Poland.; Stanczak M; Department of Biostatistics and Translational Medicine, Medical University of Lodz, 92-215 Lodz, Poland.; Kuljanin M; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Włodarczyk A; Department of Tumor Biology, Medical University of Lodz, 90-752 Lodz, Poland.; Stoczynska-Fidelus E; Department of Molecular Biology, Medical University of Lodz, 90-752 Lodz, Poland.; Taha J; Central Laboratory for Genetic Research in Pediatric Oncology 'Oncolab', Medical University of Lodz, 90-752 Lodz, Poland.; Pawlik B; Department of Pediatrics, Oncology and Hematology, Medical University of Lodz, 90-752 Lodz, Poland.; Postgraduate School of Molecular Medicine, Medical University of Warsaw, 02-004 Warsaw, Poland.; Borowiec M; Department of Clinical Genetics, Medical University of Lodz, 90-419 Lodz, Poland.; Mancias JD; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Mlynarski W; Department of Pediatrics, Oncology and Hematology, Medical University of Lodz, 90-752 Lodz, Poland.; Rieske P; Department of Tumor Biology, Medical University of Lodz, 90-752 Lodz, Poland.; Fendler W; Department of Biostatistics and Translational Medicine, Medical University of Lodz, 92-215 Lodz, Poland.; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Zmysłowska A; Department of Clinical Genetics, Medical University of Lodz, 90-419 Lodz, Poland.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101551097 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4425 (Electronic) Linking ISSN: 20734425 NLM ISO Abbreviation: Genes (Basel) Subsets: MEDLINE

Chen B; Stark DC; Jadhav PV; Lynn-Nguyen TM; Halligan BS; Rossiter NJ; Sindoni N; Shin M; Paulo JA; Chang M; Koo I; Koshkin S; Eyunni S; Ronchi P; Paulsen MT; Morlacchi P; Hanna DA; Lin J; Guerra RM; Pagliarini DJ; Banerjee R; Parolia A; Ljungman ME; Patterson AD; Mancias JD; Mosalaganti S; Sexton JZ; Calì T; Lyssiotis CA; Shah YM

Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

Dilly J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Hoffman MT; Harvard Medical School, Boston, Massachusetts.; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Abbassi L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Li Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Paradiso F; Department of Translational Molecular Pathology, Sheikh Ahmed Center for Pancreatic Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Parent BD; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Hennessey CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Jordan AC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Morgado M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Dasgupta S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Uribe GA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Yang A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Kapner KS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Hambitzer FP; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Qiang L; Harvard Medical School, Boston, Massachusetts.; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Feng H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Geisberg J; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Wang J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Evans KE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Lyu H; Therapeutics Discovery Division, TRACTION Platform, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Schalck A; Therapeutics Discovery Division, TRACTION Platform, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Feng N; Therapeutics Discovery Division, TRACTION Platform, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Lopez AM; Therapeutics Discovery Division, TRACTION Platform, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Bristow CA; Therapeutics Discovery Division, TRACTION Platform, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Kim MP; Therapeutics Discovery Division, TRACTION Platform, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Rajapakshe KI; Department of Translational Molecular Pathology, Sheikh Ahmed Center for Pancreatic Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Bahrambeigi V; Department of Translational Molecular Pathology, Sheikh Ahmed Center for Pancreatic Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Roth JA; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Garg K; Exact Sciences, Redwood City, California.; Guerrero PA; Department of Translational Molecular Pathology, Sheikh Ahmed Center for Pancreatic Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Stanger BZ; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; Cristea S; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard School of Public Health, Boston, Massachusetts.; Lowe SW; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Baslan T; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; Van Allen EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Mancias JD; Harvard Medical School, Boston, Massachusetts.; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Chan E; Amgen Inc., Thousand Oaks, California.; Anderson A; Amgen Inc., Thousand Oaks, California.; Katlinskaya YV; Amgen Inc., Thousand Oaks, California.; Shalek AK; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts.; Institute for Medical Engineering and Science, Department of Chemistry, and Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts.; Hong DS; University of Texas M.D. Anderson Cancer Center, Houston, Texas.; Pant S; University of Texas M.D. Anderson Cancer Center, Houston, Texas.; Hallin J; Mirati Therapeutics Inc., San Diego, California.; Anderes K; Mirati Therapeutics Inc., San Diego, California.; Olson P; Mirati Therapeutics Inc., San Diego, California.; Heffernan TP; Therapeutics Discovery Division, TRACTION Platform, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Chugh S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Christensen JG; Mirati Therapeutics Inc., San Diego, California.; Maitra A; Department of Translational Molecular Pathology, Sheikh Ahmed Center for Pancreatic Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Wolpin BM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Raghavan S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Nowak JA; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.; Winter PS; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Dougan SK; Harvard Medical School, Boston, Massachusetts.; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Aguirre AJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE

Fan M; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, United States.; Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China.; Lu W; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, United States.; Department of Chemical and Systems Biology, ChEM-H, Stanford Cancer Institute, School of Medicine, Stanford University, Stanford, United States.; Che J; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, United States.; Kwiatkowski NP; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, United States.; Gao Y; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, United States.; Seo HS; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, United States.; Ficarro SB; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States.; Blais Proteomics Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States.; Gokhale PC; Experimental Therapeutics Core, Dana-Farber Cancer Institute, Boston, United States.; Liu Y; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, United States.; Geffken EA; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States.; Lakhani J; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States.; Song K; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States.; Kuljanin M; Department of Cell Biology, Harvard Medical School, Boston, United States.; Division of Radiation and Genome Stability, Department of Radiation Oncology, Dana- Farber Cancer Institute, Harvard Medical School, Boston, United States.; Ji W; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, United States.; Department of Chemical and Systems Biology, ChEM-H, Stanford Cancer Institute, School of Medicine, Stanford University, Stanford, United States.; Jiang J; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, United States.; He Z; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, United States.; Tse J; Department of Chemical and Systems Biology, ChEM-H, Stanford Cancer Institute, School of Medicine, Stanford University, Stanford, United States.; Boghossian AS; Broad Institute of MIT and Harvard, Cambridge, United States.; Rees MG; Broad Institute of MIT and Harvard, Cambridge, United States.; Ronan MM; Broad Institute of MIT and Harvard, Cambridge, United States.; Roth JA; Broad Institute of MIT and Harvard, Cambridge, United States.; Mancias JD; Division of Radiation and Genome Stability, Department of Radiation Oncology, Dana- Farber Cancer Institute, Harvard Medical School, Boston, United States.; Marto JA; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States.; Blais Proteomics Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States.; Dhe-Paganon S; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, United States.; Zhang T; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, United States.; Department of Chemical and Systems Biology, ChEM-H, Stanford Cancer Institute, School of Medicine, Stanford University, Stanford, United States.; Gray NS; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, United States.; Department of Chemical and Systems Biology, ChEM-H, Stanford Cancer Institute, School of Medicine, Stanford University, Stanford, United States.

Publisher: eLife Sciences Publications, Ltd Country of Publication: England NLM ID: 101579614 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-084X (Electronic) Linking ISSN: 2050084X NLM ISO Abbreviation: Elife Subsets: MEDLINE